Adocia
Products and platforms
- Pipeline
- Technology Platforms
Careers
Partnering
Investors
Media
Contact
- Contact us
- Map and accessibility

Investors
Media
- Press releases
- Media

EN
- FR

Adocia initiates a clinical study on the post-meal effect of ultra-rapid BioChaperone Lispro insulin formulation

Previous articleHalf year report on Adocia’s liquidity agreement with Kepler Capital Markets

Next articleAdocia reports positive results from phase IIa clinical study of fast-acting human insulin, HinsBet

Adocia
Products and platforms
Careers
Partnering
Investors
Media
Contact

Contact us

+33(0)4 72 610 610 contact@adocia.com

Adocia
115 Avenue Lacassagne
69003 Lyon, France

2026 © Adocia

Site plan
Legal notice
Privacy policy and cookies policy
Managing cookies

Website by

Un Brin de Campagne